SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-013334
Filing Date
2020-04-06
Accepted
2020-04-06 17:14:40
Documents
1
Period of Report
2020-04-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1396
  Complete submission text file 0001127602-20-013334.txt   2737
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RESTORBIO, INC. 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address
FONTEYNE PAUL R. (Reporting) CIK: 0001727550 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 20777723